What is it about?
To shed light on the complex problem of the poor responder patient undergoing ART, the POSEIDON Group -created in 2015 under the initiative of Prof. Alviggi from Italy- discussed and elaborated practical solutions concerning the diagnosis and management of the poor responder patient undergoing ART.
Featured Image
Why is it important?
You should care about the new Poseidon criteria because they propose a unique and more detailed stratification of low responders to ovarian stimulation, which represents a significant proportion of patients we treat in our daily practice.
Perspectives
Read the Original
This page is a summary of: The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome, F1000Research, December 2016, Faculty of 1000, Ltd.,
DOI: 10.12688/f1000research.10382.1.
You can read the full text:
Resources
Why the POSEIDON classification
A video lecture explaining why the new Poseidon criteria was developed.
The ART Calculator: estimating the new marker of success in ART
A video lecture explaining the importance of estimating the number of oocytes required to obtain at least one euploid blastocyst for transfer in each patient.
Contributors
The following have contributed to this page